Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > NO ONE GIVING THEIR .02 cents WORTH? .01 CENTS WORTH
View:
Post by losingmyshirt on Jul 15, 2021 4:27pm

NO ONE GIVING THEIR .02 cents WORTH? .01 CENTS WORTH

THE PUMPERS HAVE PACKED THEIR BAGS AND HAVE CALLED IT DONE.



Friday could be the BIG DAY. It has been long awaited. 

What Kalytera needs is Massive Volume. Will the Friday SELL-OFF show us .01?

Go KALYTERA!

Kaboom!
Comment by Mick00333 on Jul 16, 2021 8:54am
Still crying my dude... take your bags and leave like u said we dont need you here we never wanted you to be honest :D 
Comment by PTBailey on Jul 17, 2021 10:18am
Comment by Dude51 on Jul 17, 2021 12:39pm
Hey, wake up and smell the year, where now called Claritas.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities